Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Ferroptosis is a regulated cell death (RCD) mechanism driven by iron-dependent lipid peroxidation.
• It is a key strategy for overcoming tumor resistance, but cancer cells can develop resistance to ferroptosis.
• Understanding ferroptosis induction and resistance mechanisms is crucial for cancer therapy.

Purpose of the Study:

• To investigate ferroptosis induction mechanisms in cancer cells.
• To discuss cancer cell resistance to ferroptosis and its underlying causes.
• To explore nanoparticle-based strategies and combination therapies to overcome ferroptosis resistance.

Main Methods:

• Literature review of ferroptosis induction and resistance mechanisms.
• Analysis of ferroptosis-suppressing biomarkers.
• Evaluation of nanoparticle-mediated ferroptosis induction.
• Exploration of combination strategies involving ferroptosis, other cell death types, and immunotherapy.

Main Results:

• Ferroptosis induction pathways and cancer cell resistance mechanisms were detailed.
• Novel ferroptosis-suppressing biomarkers were identified.
• Nanoparticles show potential for inducing ferroptosis and overcoming resistance.
• Combination therapies (ferroptosis with apoptosis, cuproptosis, autophagy, immunotherapy) present promising avenues.

Conclusions:

• Nanoparticle-based ferroptosis induction is a viable strategy to circumvent cancer cell resistance.
• Combining ferroptosis with other cell death modalities and immunotherapy can enhance anti-tumor efficacy.
• Further research into these combination strategies is warranted for clinical translation.